Cited by 1,957Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 151 of the 152 references it cites were found in a registry or an index.

The molecular logic of endocannabinoid signalling

Open access

Piomelli, Daniele·2003·Nature Reviews Neuroscience

DOI 10.1038/nrn1247

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1038/nrn1247

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“1 ), which led eventually to the pharmacological identification of cannabinoid-sensitive sites in the brai”
Background
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

Flagged first, then by citations

Show all 152 references

1 of the 152 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Rouyer, M. Sur les medicaments usuels des Egyptiens. Bull. Pharmacie 2, 25 (1810).
O'Shaugnessy, W. B. On the Cannabis indica or Indian hemp. Pharmacol. J. Trans. 2, 594 (1843).
Christison, R. in A Dispensatory, or Commentary on the Pharmacopoeias of Great Britain (and the United States) 971–974 (Lea and Blanchard, Philadelphia, 1848).
Adams, R. Marihuana. Harvey Lect. 37, 168 (1941).

Sorted by citations

Items 701–800 of 1,006

Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists
Behrenswerth, A., Volz, N., Toräng, J., Hinz, S., Bräse, S., & Müller, C. E. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.027 · Cited by 53
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress
Bedse, G., Colangeli, R., Lavecchia, A. M., Romano, A., Fabio Altieri, F., Cifani, C., Cassano, T., & Gaetani, S. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.005 · Cited by 52
Effects of endocannabinoid and endovanilloid systems on aversive memory extinction
Laricchiuta, D., Centonze, D., & Petrosini, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.010 · Cited by 54
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
Romero‐Sanchiz, P., Nogueira‐Arjona, R., Pastor, A., Araos, P. F., Serrano, A., Boronat, A., García‐Marchena, N., Mayoral, F., Bordallo-Aragón, A., Alén, F., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.026 · Cited by 53
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases
Bellocchio, L., MANCINI, G., Vicennati, V., Pasquali, R., & Pagotto, U. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.09.001 · Cited by 52
Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid
Koethe, D., Schreiber, D., Giuffrida, A., Mauss, C., Faulhaber, J., Heydenreich, B., Hellmich, M., Graf, R., Klosterkötter, J., Piomelli, D., et al. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-008-0169-6 · Cited by 51
Self-citation
Post‐ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death
Pellegrini-Giampietro, D. E., Mannaioni, G., & Bagetta, G. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06765.x · Cited by 50
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments
Stornaiuolo, M., Bruno, A., Botta, L., Regina, G. L., Cosconati, S., Silvestri, R., Marinelli, L., & Novellino, E. (2015) · Scientific Reports · doi:10.1038/srep15453 · Cited by 53
A Key Agonist-induced Conformational Change in the Cannabinoid Receptor CB1 Is Blocked by the Allosteric Ligand Org 27569
Fay, J. F., & Farrens, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.352328 · Cited by 52
Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm
von Rüden, E., Jafari, M., Bogdanović, R. M., Wotjak, C. T., & Potschka, H. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.001 · Cited by 51
Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis
Pelayo‐Terán, J. M., Suárez‐Pinilla, P., Chadi, N., & Crespo‐Facorro, B. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884609 · Cited by 51
Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2
Arnold, W. R., Weigle, A. T., & Das, A. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.03.016 · Cited by 51
Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases
Śledziński, P., Nowak, A., & Zeyland, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010263 · Cited by 53
A possible role for the endocannabinoid system in the neurobiology of depression
Serra, G., & Fratta, W. (2007) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-3-25 · Cited by 51
Immune control by endocannabinoids — New mechanisms of neuroprotection?
Ullrich, O., Merker, K., Timm, J., & Tauber, S. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.018 · Cited by 50
NMDA receptors induce somatodendritic secretion in hypothalamic neurones of lactating female rats
De Kock, C. P. J., Burnashev, N., Lodder, J. C., Mansvelder, H. D., & Brussaard, A. B. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.069005 · Cited by 50
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
Murphy, T., & Foll, B. L. (2020) · Biomolecules · doi:10.3390/biom10060855 · Cited by 53
Biological specificity of visceral adipose tissue and therapeutic intervention
Perrini, S., Leonardini, A., Laviola, L., & Giorgino, F. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802334752 · Cited by 50
Expression and Function of Endocannabinoid Receptors in the Human Adrenal Cortex
Ziegler, C. G., Mohn, C. E., Lamounier‐Zepter, V., Rettori, V., Bornstein, S., Krug, A. W., & Ehrhart‐Bornstein, M. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1241860 · Cited by 50
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation
Gaffal, E., Cron, M., Glodde, N., Bald, T., Kuner, R., Zimmer, A., Lutz, B., & Tüting, T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201777 · Cited by 50
Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
Blázquez, C., Carracedo, A., Salazar‐Roa, M., Lorente, M., Egia, A., González‐Feria, L., Haro, A., Velasco, G., & Guzmán, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.021 · Cited by 51
Calcium signaling and synaptic modulation: Regulation of endocannabinoid-mediated synaptic modulation by calcium
Ohno‐Shosaku, T., Hashimotodani, Y., Maejima, T., & Kano, M. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.014 · Cited by 50
The Cannabidiol Use in the Treatment of Epilepsy
Matos, R. L. A., Spinola, L. A., Barboza, L. L., Garcia, D. R., França, T. C. C., & Affonso, R. S. (2017) · Revista Virtual de Química · doi:10.21577/1984-6835.20170049 · Cited by 62
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling
Basavarajappa, B. S. (2015) · Brain Sciences · doi:10.3390/brainsci5040456 · Cited by 48
Cannabinoid CB1Receptor-Dependent Long-Term Depression in Autaptic Excitatory Neurons
Kellogg, R. T., Mackie, K., & Straiker, A. J. (2009) · Journal of Neurophysiology · doi:10.1152/jn.00266.2009 · Cited by 51
On the interaction between drugs of abuse and adolescent social behavior
Trezza, V., Baarendse, P. J. J., & Vanderschuren, L. J. M. J. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3471-z · Cited by 53
Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet
Flamment, M., Guéguen, N., Wetterwald, C., Simard, G., Malthièry, Y., & Ducluzeau, P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00169.2009 · Cited by 54
Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum
Tebano, M. T., Martire, A., Chiodi, V., Pepponi, R., Ferrante, A., Domenici, M. R., Frank, C., Chen, J., Ledent, C. A., & Popoli, P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06282.x · Cited by 49
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia
Ferreira‐Junior, N. C., Pereira, M. D. S., Guimarães, F. S., & Bel, E. D. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00109-8 · Cited by 53
The endocannabinoid hydrolase FAAH is an allosteric enzyme
Dainese, E., Oddi, S., Simonetti, M., Sabatucci, A., Angelucci, C. B., Ballone, A., Dufrusine, B., Fezza, F., Fabritiis, G. D., & Maccarrone, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-59120-1 · Cited by 57
Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome
Müller‐Vahl, K., Bîndilă, L., Lutz, B., Mußhoff, F., Skripuletz, T., Baumgaertel, C., & Sühs, K. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0671-6 · Cited by 49
Nutritional aspects modulating brain development and the responses to stress in early neonatal life
Walker, C. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.010 · Cited by 47
Cannabinoids and neuronal damage: Differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures
Kreutz, S., Koch, M., Ghadban, C., Korf, H., & Dehghani, F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.010 · Cited by 49
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Bernal‐Chico, A., Tepavčević, V., Manterola, A., Utrilla, C. L., Matute, C., & Mato, S. (2022) · Glia · doi:10.1002/glia.24172 · Cited by 50
G protein-coupled receptors in stem cell maintenance and somatic reprogramming to pluripotent or cancer stem cells
Choi, H. Y., Saha, S. K., Kim, K., Kim, S., Yang, G., Kim, B., Kim, J., & Cho, S. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.2.250 · Cited by 48
New insights on food intake control by olfactory processes: The emerging role of the endocannabinoid system
Gómez, E. S., Bellocchio, L., & Marsicano, G. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.023 · Cited by 48
Fatty Acid Binding Receptors and Their Physiological Role in Type 2 Diabetes
Swaminath, G. (2008) · Archiv der Pharmazie · doi:10.1002/ardp.200800096 · Cited by 49
Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
Marco, E. M., Rapino, C., Caprioli, A., Borsini, F., Laviola, G., & Maccarrone, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137034 · Cited by 49
FAAH inhibition as a preventive treatment for migraine: A pre-clinical study
Greco, R., Demartini, C., Zanaboni, A. M., Tumelero, E., Reggiani, A. M., Misto, A., Piomelli, D., & Tassorelli, C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104624 · Cited by 50
Self-citation
DARK Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice/K2)
Worob, A., & Wenthur, C. J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00586 · Cited by 47
Development of Radioligands for In Vivo Imaging of Type 1 Cannabinoid Receptors (CB1) in Human Brain
Horti, A. G., & Laere, K. V. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549380 · Cited by 49
Endocannabinoid regulation of relapse mechanisms
Fattore, L., Fadda, P., & Fratta, W. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.004 · Cited by 49
INTERACTIONS BETWEEN CANNABINOID AND OPIOID RECEPTOR SYSTEMS IN THE MEDIATION OF ETHANOL EFFECTS
Manzanares, J., Ortiz, S., Oliva, J. M., Pérez-Rial, S., & Palomo, T. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh112 · Cited by 48
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi, J. F. C., Ferreira, F. R., Silva-Amaral, D., Lima, D. D. A., Hallak, J. E. C., Zuardi, A. W., Bel, E. A. D., Guimarães, F. S., Costa, K. C. M., Campos, A. C., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06196-4 · Cited by 53
The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
Coelho, M., Duarte, P., Calado, M. S., Almeida, A. J., Reis, C. P., & Gaspar, M. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121838 · Cited by 47
The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy
Slusar, J. E., Cairns, E. A., Szczesniak, A.-M., Bradshaw, H. B., Polo, A. D., & Kelly, M. E. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.018 · Cited by 46
Cannabinoids Biology: The Search for New Therapeutic Targets
Felder, C. C. (2006) · Molecular Interventions · doi:10.1124/mi.6.3.6 · Cited by 47
Lipid rafts regulate 2‐arachidonoylglycerol metabolism and physiological activity in the striatum
Maccarrone, M., Chiara, V. D., Gasperi, V., Viscomi, M. T., Rossi, S., Oddi, S., Molinari, M., Musella, A., Finazzi‐Agrò, A., & Centonze, D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05948.x · Cited by 47
Ten years of Nature Reviews Neuroscience: insights from the highly cited
Luo, L., Rodríguez, E., Jerbi, K., Lachaux, J.-P., Martinerie, J. M., Corbetta, M., Shulman, G. L., Piomelli, D., Turrigiano, G. G., Nelson, S. B., et al. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2912 · Cited by 47
Self-citation
Endocannabinoids are Involved in Male Vertebrate Reproduction: Regulatory Mechanisms at Central and Gonadal Level
Bovolin, P., Cottone, E., Pomatto, V., Fasano, S., Pierantoni, R., Cobellis, G., & Meccariello, R. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00054 · Cited by 48
Cocaine-Induced Behavioral Sensitization Is Associated With Changes in the Expression of Endocannabinoid and Glutamatergic Signaling Systems in the Mouse Prefrontal Cortex
Blanco, E., Pavón, F. J., Palomino, A., Rojas, M. J. L., Serrano, A., Rivera, P., Bilbao, A., Alén, F., Vida, M., Suárez, J., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu024 · Cited by 47
Bile Acid Recognition by NAPE-PLD
Margheritis, E. G., Castellani, B., Magotti, P., Peruzzi, S., Romeo, E., Natali, F., Mostarda, S., Gioiello, A., Piomelli, D., & Garau, G. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00624 · Cited by 47
Self-citation
Cannabinoids as therapeutics for PTSD
Sbarski, B., & Akirav, I. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107551 · Cited by 47
Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear
Ivy, D. M., Palese, F., Vozella, V., Fotio, Y., Yalcin, A., Ramirez, G. L., Mears, D. J., Wynn, G. H., & Piomelli, D. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0696-x · Cited by 47
Self-citation
Epigenetics and the endocannabinoid system signaling: An intricate interplay modulating neurodevelopment
Gomes, T. M., da Silva, D. D., Carmo, H., Carvalho, F. D., & Silva, J. P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105237 · Cited by 49
Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity
Fezza, F., Gasperi, V., Mazzei, C., & Maccarrone, M. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.005 · Cited by 47
The endocannabinoid system as a target for modelling psychosis
Koethe, D., Hoyer, C., & Leweke, F. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1591-7 · Cited by 47
Pharmacological activation of kainate receptors drives endocannabinoid mobilization
Lourenço, J., Matias, I., Marsicano, G., & Mulle, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3512-10.2011 · Cited by 46
Anatomical characterization of the cannabinoid CB1 receptor in cell‐type–specific mutant mouse rescue models
Gutiérrez‐Rodríguez, A., Puente, N., Elezgarai, I., Ruehle, S., Lutz, B., Reguero, L., Gerrikagoitia, I., Marsicano, G., & Grandes, P. (2017) · Journal of Comparative Neurology · doi:10.1002/cne.24066 · Cited by 46
Radiosynthesis and Evaluation of [11C- Carbonyl ]‑Labeled Carbamates as Fatty Acid Amide Hydrolase Radiotracers for Positron Emission Tomography
Wilson, A. A., Hicks, J. W., Sadovski, O., Parkes, J., Tong, J., Houle, S., Fowler, C. J., & Vasdev, N. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301492y · Cited by 48
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users
Crane, N. A., Schuster, R. M., Mermelstein, R. J., & González, R. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1020770 · Cited by 46
The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness
Campolongo, P., Ratano, P., Manduca, A., Scattoni, M. L., Palmery, M., Trezza, V., & Cuomo, V. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00011 · Cited by 52
Discovery and Development of Endocannabinoid-Hydrolyzing Enzyme Inhibitors
Minkkilä, A., Saario, S. M., & Nevalainen, T. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791164238 · Cited by 46
Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases
Milando, R., & Friedman, A. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-018-0410-5 · Cited by 50
The challenge of brain lipidomics
Piomelli, D. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.09.006 · Cited by 46
Self-citation
Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum
Narushima, M., Hashimoto, K., & Kano, M. (2006) · Neuroscience Research · doi:10.1016/j.neures.2005.12.004 · Cited by 46
Analgesic Effect of a Mixed T-Type Channel Inhibitor/CB2 Receptor Agonist
Gadotti, V. M., You, H., Petrov, R. R., Berger, N. D., Diaz, P., & Zamponi, G. W. (2013) · Molecular Pain · doi:10.1186/1744-8069-9-32 · Cited by 45
Expression and localization of the cannabinoid receptor type 1 and the enzyme fatty acid amide hydrolase in the retina of vervet monkeys
Bouskila, J., Burke, M., Zabouri, N., Casanova, C., Ptito, M., & Bouchard, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.041 · Cited by 45
Social encounter with a novel partner in adolescent rats: Activation of the central endocannabinoid system
Marco, E. M., Rapino, C., Caprioli, A., Borsini, F., Maccarrone, M., & Laviola, G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.044 · Cited by 49
Molecular mechanisms of cannabinoid addiction
Fratta, W., & Fattore, L. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.02.002 · Cited by 46
The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats
Sink, K. S., Segovia, K. N., Collins, L. E., Markus, E. J., Vemuri, K. V., Makriyannis, A., & Salamone, J. D. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.011 · Cited by 44
The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism.
González-Aparicio, R., Blanco, E., Serrano, A., Pavón, F., Parsons, L., Maldonado, R., Robledo, P., Fernández-Espejo, E., & de Fonseca, F. D. (2014) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001259 · Cited by 44
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.
Carey, C. E., Agrawal, A., Zhang, B., Conley, E. D., Degenhardt, L. J., Heath, A. C., Li, D., Lynskey, M. T., Martin, N. G., Montgomery, G. W., et al. (2015) · Journal of Abnormal Psychology · doi:10.1037/abn0000079 · Cited by 47
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
Rodrigues, R. S., Lourenço, D. M., Paulo, S. L., Mateus, J. M., Ferreira, M. F., Mouro, F. M., Moreira, J. B., Ribeiro, F. F., Sebastião, A. M., & Xapelli, S. (2019) · Molecules · doi:10.3390/molecules24071350 · Cited by 47
The cannabinoid WIN 55,212‐2‐mediated protection of dentate gyrus granule cells is driven by CB1receptors and modulated by TRPA1 and Cav2.2 channels
Koch, M., Kreutz, S., Böttger, C., Grabiec, U., Ghadban, C., Korf, H., & Dehghani, F. (2010) · Hippocampus · doi:10.1002/hipo.20772 · Cited by 45
Effects of endocannabinoid neurotransmission modulators on brain stimulation reward
Vlachou, S., Nomikos, G. G., & Panagis, G. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0506-0 · Cited by 47
Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain
Hermann, H., & Lutz, B. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.080 · Cited by 45
Involvement of the GABAergic system in PTSD and its therapeutic significance
Huang, J., Xu, F., Yang, L.-P., Tuolihong, L., Wang, X., Du, Z., Zhang, Y., Yin, X., Li, Y.-J. D., Lu, K., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1052288 · Cited by 41
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease
Amandine, E. B., & Marchalant, Y. (2015) · Aging and Disease · doi:10.14336/ad.2015.0617 · Cited by 43
Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training
Bystrowska, B., Smaga, I., Frankowska, M., & Filip, M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.002 · Cited by 45
Cannabinoid type 1 receptors located on single-minded 1–expressing neurons control emotional behaviors
Dubreucq, S., Kambiré, S. J., Conforzi, M., Metna‐Laurent, M., Cannich, A., Gómez, E. S., Richard, É. M., Marsicano, G., & Chaouloff, F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.049 · Cited by 44
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems
Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G. M., Drago, F., & Marzo, V. D. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.015 · Cited by 44
Interactions between specific parameters of cannabis use and verbal memory
Wagner, D. R., Becker, B., Gouzoulis‐Mayfrank, E., & Daumann, J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.004 · Cited by 44
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia
Arnold, J. C., Boucher, A. A., & Karl, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884726 · Cited by 45
Neuron to Astrocyte Communication via Cannabinoid Receptors Is Necessary for Sustained Epileptiform Activity in Rat Hippocampus
Coiret, G., Ster, J., Grewe, B. F., Wendling, F., Helmchen, F., Gerber, U. R., & Benquet, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037320 · Cited by 44
Anxiety-like responses induced by nitric oxide within the BNST in mice: Role of CRF1 and NMDA receptors
Faria, M. P., Miguel, T. T., Gomes, K. S., & Nunes‐de‐Souza, R. L. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.01.002 · Cited by 44
Selectively Impaired Endocannabinoid-Dependent Long-Term Depression in the Lateral Habenula in an Animal Model of Depression
Park, H.-Y., Rhee, J., Lee, S., & Chung, C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.049 · Cited by 43
Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis
Melgar‐Lesmes, P., Perramón, M., & Jiménez, W. (2019) · Cells · doi:10.3390/cells8111311 · Cited by 45
[Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?].
Saito, V. M., Wotjak, C. T., & Moreira, F. A. (2010) · PubMed · Cited by 43
Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids
Öz, M., Tchugunova, Y. B., & Dinç, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.052 · Cited by 44
15-Deoxy-Δ12,14-prostaglandin J2-Glycerol Ester, a Putative Metabolite of 2-Arachidonyl Glycerol, Activates Peroxisome Proliferator Activated Receptor γ
Raman, P., Kaplan, B. L. F., Thompson, J. T., Heuvel, J. P. V., & Kaminski, N. E. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070441 · Cited by 44
Structure–Activity Relationships of Phenylalkylamines as Agonist Ligands for 5‐HT2A Receptors
Blaazer, A. R., Smid, P., & Kruse, C. G. (2008) · ChemMedChem · doi:10.1002/cmdc.200800133 · Cited by 43
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence
Lisboa, S. F. D. S., Borges, A. A., Nejo, P., Fassini, A., Guimarães, F. S., & Resstel, L. B. M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.005 · Cited by 44
Covalent Inhibitors of Fatty Acid Amide Hydrolase: A Rationale for the Activity of Piperidine and Piperazine Aryl Ureas
Palermo, G., Branduardi, D., Masetti, M., Lodola, A., Mor, M., Piomelli, D., Cavalli, A., & Vivo, M. D. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2004283 · Cited by 44
Self-citation
An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity
Lovelace, J. W., Corches, A., Vieira, P. A., Hiroto, A. S., Mackie, K., & Korzus, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.034 · Cited by 43
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention
Zer‐Aviv, T. M., Segev, A., & Akirav, I. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000253 · Cited by 43
Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure
Miller, S., Leishman, E., Oehler, O., Daily, L., Murataeva, N., Wager‐Miller, J., Bradshaw, H. B., & Straiker, A. J. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19437 · Cited by 43
Endocannabinoids exert CB 1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein
Xu, C., Hermes, D. J., Nwanguma, B., Jacobs, I. R., Mackie, K., Mukhopadhyay, S., Lichtman, A. H., Ignatowska-Jankowska, B. M., & Fitting, S. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.07.003 · Cited by 43
Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice
Cavener, V. S., Gaulden, A. D., Pennipede, D., Jagasia, P., Uddin, J., Marnett, L. J., & Patel, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00479 · Cited by 43
Health benefits of 4,4-dimethyl phytosterols: an exploration beyond 4-desmethyl phytosterols
Zhang, T., Liu, R., Chang, M., Jin, Q., Zhang, H., & Wang, X. (2019) · Food & Function · doi:10.1039/c9fo01205b · Cited by 43

Authors: Piomelli, D.
Affiliations: University of California, Irvine (US)
Corresponding author: Piomelli, Daniele
ORCID: Piomelli, Daniele
Venue: Nature Reviews Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2003-11
Volume: 4
Issue: 11
Pages: 873-884
ISSN: 1471-003X (ISSN-L)
1471-0048
DOI: 10.1038/nrn1247
OpenAlex: W2080649553
Cited by: 1,957
References: 152
Citations by year: 2026: 39 · 2025: 42 · 2024: 43 · 2023: 50 · 2022: 76 · 2021: 77 · 2020: 81 · 2019: 71 · 2018: 67 · 2017: 79 · 2016: 81 · 2015: 100 · 2014: 100 · 2013: 95 · 2012: 108
FWCI: 9.35
Type: journal article
Language: en
Open access: green
escholarship.org
Licence: cc-by
www.springer.com/tdm (tdm)
Locations: Nature reviews. Neuroscience (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders: National Alliance for Research on Schizophrenia and Depression
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: endocannabinoids, endocannabinoid signaling, CB1 receptor, delta-9-tetrahydrocannabinol, cannabinoid receptors, neurotransmitter release, ion channel modulation, synaptic plasticity, axon terminals
MeSH terms: Animals, Cannabis, gamma-Aminobutyric Acid, Hallucinogens, Humans, Synaptic Transmission, Dronabinol, Signal Transduction, Neurotransmitter Agents, Glutamic Acid, Receptor, Cannabinoid, CB1, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The molecular logic of endocannabinoid signalling

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks